Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. - Wikidata - awgldk - TriplyDB

Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.

Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.

http://www.wikidata.org/entity/Q37924914

about

Obesity associated hypertension: new insights into mechanism Variant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index.New insights into pancreatic cancer-induced paraneoplastic diabetes Recent developments in near-infrared spectroscopy (NIRS) for the assessment of local skeletal muscle microvascular function and capacity to utilise oxygen The fibrosis-cell death axis in heart failure Transcriptome-wide RNA sequencing analysis of rat skeletal muscle feed arteries. I. Impact of obesity Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women.Peripheral vascular response to inspiratory breath hold in paediatric homozygous sickle cell disease Interaction between maternal and offspring diet to impair vascular function and oxidative balance in high fat fed male mice.Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease.Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertension Dynamics of microvascular blood flow and oxygenation measured simultaneously in human skin.Body mass index is related to microvascular vasomotion, this is partly explained by adiponectin.Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.Effects of Incretin-Based Therapies on Neuro-Cardiovascular Dynamic Changes Induced by High Fat Diet in Rats Prehypertension in adolescents with cardiovascular risk: a comparison between type 1 diabetic patients and overweight subjects.Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance.Acute Thermotherapy Prevents Impairments in Cutaneous Microvascular Function Induced by a High Fat Meal.Microvascular Blood Flow Improvement in Hyperglycemic Obese Adult Patients by Hypocaloric Diet.Relaxin treatment reverses insulin resistance in mice fed a high-fat diet Overweight status is associated with extensive signs of microvascular dysfunction and cardiovascular risk Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance.The microcirculation in adipose tissue inflammation.G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.The microvasculature: a target for nutritional programming and later risk of cardio-metabolic disease.Metabolic memory: mechanisms and implications for diabetic vasculopathies.Developmental conditioning of the vasculature.Abnormal Rho-associated kinase activity contributes to the dysfunctional myogenic response of cerebral arteries in type 2 diabetes.Adrenergic signaling in heart failure and cardiovascular aging.The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.Evaluation of microvascular endothelial function in patients with infective endocarditis using laser speckle contrast imaging and skin video-capillaroscopy: research proposal of a case control prospective study.Microvascular contributions to insulin resistance.Functional status of microvascular vasomotion is impaired in spontaneously hypertensive rat.Association of body mass index and weight gain patterns with albumin excretion in pregnancy.Sleep quality and duration are related to microvascular function: the Amsterdam Growth and Health Longitudinal Study.Multiorgan, Multimodality Imaging in Cardiometabolic Disease.Microvascular dysfunction affects the development and prognosis of sudden idiopathic hearing loss.Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension.

P2860

Q26827389-662943D9-6248-4BC7-B252-E61444986CE2 Q27304646-ECD897CA-9BDB-47F3-B222-FAE3EF89FEE1 Q27687766-75580F44-EF40-4340-ADAE-629DA8155FB6 Q28067731-21F5FEFE-CBD8-4598-895E-5C76B18A7AD1 Q28076570-6326E0C2-E600-46C2-ABB7-88EF2FF96E17 Q28386749-CA312249-6DC5-4F74-90B7-60558D5E0488 Q30657461-8F0D7791-8525-4FF2-8AB4-02597451C412 Q33908454-A71ED1DF-CC6F-4B2F-A750-F65D6331D72C Q34290485-4EF4CF95-65B7-42A8-B37E-FC6185D35173 Q34507047-D6CF352D-4A55-4B71-9B48-A61C5D9C09C9 Q34709131-A4AAAF67-8735-4D33-A0E1-3595BB1FBCC2 Q34774261-99A54624-3604-4F5E-A3CE-D41318164498 Q35136858-7CC82AC6-61A1-4E5F-9FBE-CA36128EFF8F Q35172921-EB95411A-A2A4-426A-9C07-E06E479CF36C Q35576849-5C5C8DD3-204C-454E-8336-3BB76ADE8E56 Q35909469-714331A4-5BD6-47D6-A539-A3848561298F Q35934393-F8E3BFCF-4655-4B33-A2D7-EAF953D64611 Q36108506-42FF0126-36DD-4D01-BD0B-8495CFEDECA6 Q36123029-917FFFBB-77EE-4C52-9A34-2817AB166C3C Q36206352-819011CF-39DF-4512-A33B-5EB844E069B5 Q37110579-96AACB2D-CA7C-450D-A48E-68D0AE9A170A Q37220133-873A1235-2AEE-40D1-AAC4-360EF635DD61 Q38072622-76186289-A308-4B2E-AFCD-4B32F834BDD7 Q38078880-8519AC11-AF52-4720-B7B6-11F27A47A93B Q38093493-8F2E2006-1015-4500-B261-36BEE800CBFD Q38113859-F3ADE56A-9EC7-40BF-B009-3AC5E58E2F92 Q38238034-7EF710B4-6CC4-497E-8AE2-1BDE29B00A55 Q38318645-8F2D9F20-6A55-481D-8731-955581CE4983 Q38347318-0264C0BD-CCD3-4032-A715-DFCC573E8599 Q38803622-69D204BA-409F-4EBB-A934-78A50647583D Q39238938-8341AED1-75AA-4A24-8240-4E7BAE53AF00 Q40115301-38ED63FB-3228-41A1-B719-77DC52881BB8 Q42591131-F3911448-26C4-4CB5-9A36-8C27381A5589 Q47131073-408B168E-A18B-4CEB-9912-A43FAB91ED90 Q47173914-BFD4EA1D-E764-4BB3-9325-EA6345FB0239 Q48016324-694AE2D6-287E-4D49-9C31-0CBF50A15473 Q50084370-5D3727C7-D775-4CF2-90A6-E75859A31723 Q50315561-4149D6DE-7BA2-4D31-9F68-32A9F4655749 Q50550209-A88178DB-023F-4CF1-B85B-A9A2737B531E Q53345306-F6A5F999-4032-400E-BDEE-3B81EEE5C52E

P2860

Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.

http://www.wikidata.org/entity/Q37924914

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Microvascular dysfunction: a p ...... n resistance and hypertension.

@en

Microvascular dysfunction: a p ...... n resistance and hypertension.

@nl

type

label

Microvascular dysfunction: a p ...... n resistance and hypertension.

@en

Microvascular dysfunction: a p ...... n resistance and hypertension.

@nl

prefLabel

Microvascular dysfunction: a p ...... n resistance and hypertension.

@en

Microvascular dysfunction: a p ...... n resistance and hypertension.

@nl

P1433

Q37924914-0F44CA3E-953E-466F-BD21-E944DD15B6DC

P1476

Q37924914-80AA59C8-04CD-4015-9A70-F62C8AA5D06D

P2093

Q37924914-3ACF232D-1C20-409C-8D03-26A9DC4BD8D5

Q37924914-490D9FA0-C5DB-4D8B-9630-513217371DB7

Q37924914-914352BC-302B-4E87-978E-1000DDF4A096

Q37924914-BC0EA45F-64E1-44A4-BB6A-E9FD52C2A936

Q37924914-C307B252-1C66-45F6-9387-3AAD544E9BBF

Q37924914-D82C57E1-CAB5-40A3-A08D-026A2D610DEE

Q37924914-E28733B7-14E2-4B19-831D-AAD08CE9FC8D

P2860

Q37924914-00F24F14-68CB-4862-B759-7B98A0B8668C

Q37924914-03A73E1C-FBB9-4B4B-B19A-5A218278CA14

Q37924914-04DCB7A4-F5E7-485A-827B-8C788C90E2F8

Q37924914-0649FD18-C70E-4BBA-AFE4-3F8A3336760B

Q37924914-0832F229-3E59-4B8B-8E76-154E7177B12D

Q37924914-0D0873F8-AE58-43C2-A497-89FC70E730FB

Q37924914-1060108A-B897-40E4-BE72-FED8CDB4F036

Q37924914-115A7164-B70B-413E-8261-B268EC80D288

Q37924914-14A1196F-55D1-4564-8F54-8639BA302175

Q37924914-14F7EDB9-0B13-43AF-BA61-EEE1ABB9CFE1

P304

Q37924914-FB561528-EDAF-4E60-9FC0-8418E0B33D34

P31

Q37924914-06C83DD5-E523-4715-B690-2ABA11B8164A

P356

Q37924914-C65B5053-5F03-4D84-A4ED-BA7E14EC4669

P433

Q37924914-9E612B03-D3B3-44DC-850B-976147575128

P478

Q37924914-81418CAD-75DA-4960-A64F-713D7EDF97D9

P50

Q37924914-7EFB14BF-BDCE-45A8-B8A9-69181DCF8B29

Q37924914-965D0688-2EE8-46ED-894D-7F8544129FC3

P577

Q37924914-2AEA5DAF-7942-4735-A30D-60FB37A6691C

P5875

Q37924914-714E4131-21E9-4C2C-AF4C-D902BA38530A

P698

Q37924914-6D6654A2-7CEA-4E86-9C7C-529619F3F95C

P921

Q37924914-1A611488-B44F-4E2A-BE7B-6E1465F89758

Q37924914-6177F316-DF99-4D6A-A337-7146C48254B3

Q37924914-7A2F311C-50EA-4D8A-8886-439D1B4AE22D

Q37924914-F263E9E5-2853-437D-A71B-4A75D31803F4

P356

J.1549-8719.2011.00130.X

P1433

Microcirculation

P1476

Microvascular dysfunction: a p ...... in resistance and hypertension

@en

P2093

Alphons J Houben

http://www.w3.org/2001/XMLSchema#string

Amy M Jonk

http://www.w3.org/2001/XMLSchema#string

Coen D Stehouwer

http://www.w3.org/2001/XMLSchema#string

Erik H Serné

http://www.w3.org/2001/XMLSchema#string

Michiel P De Boer

http://www.w3.org/2001/XMLSchema#string

Nienke J Wijnstok

http://www.w3.org/2001/XMLSchema#string

Yvo M Smulders

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure

Effect of valsartan on the incidence of diabetes and cardiovascular events

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

A central role for JNK in obesity and insulin resistance

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

Caveolin-1 is required for vascular endothelial insulin uptake.

Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.

Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal.

P304

5-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1549-8719.2011.00130.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51611974

http://www.w3.org/2001/XMLSchema#string

P698

21883642

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension